ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

ANGO AngioDynamics Inc

6.12
-0.20 (-3.16%)
24 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
AngioDynamics Inc NASDAQ:ANGO NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.20 -3.16% 6.12 5.85 6.74 6.3684 6.04 6.32 459,506 01:00:00

AngioDynamics to Present at the Barclays Global Healthcare Conference

26/02/2019 9:01pm

Business Wire


AngioDynamics (NASDAQ:ANGO)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more AngioDynamics Charts.

AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that Jim Clemmer, President and Chief Executive Officer, and Michael C. Greiner, Executive Vice President and Chief Financial Officer, will present at the Barclays Global Healthcare Conference at 4:20 p.m. ET on Wednesday, March 13, 2019 in Miami Beach, FL.

A live webcast of the presentation will be accessible through the “Investors” section of the Company’s website at www.angiodynamics.com and will be available for replay following the event.

About AngioDynamics, Inc.

AngioDynamics, Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, peripheral vascular disease, and oncology. AngioDynamics’ diverse product lines include market-leading ablation systems, fluid management systems, vascular access products, angiographic products and accessories drainage products, thrombolytic products and venous products. For more information, visit www.angiodynamics.com.

Investor:AngioDynamics, Inc.Michael C. Greiner, Executive Vice President & CFO(518) 795-1821

1 Year AngioDynamics Chart

1 Year AngioDynamics Chart

1 Month AngioDynamics Chart

1 Month AngioDynamics Chart

Your Recent History

Delayed Upgrade Clock